These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 6985151)

  • 1. [Epidemiology of cardiovascular diseases in Poland and the results of the Polish Experiment with regard to the multifactorial prevention of ischemic heart disease conducted in Warsaw and Southern Poland].
    Rywik S; Sznajd J
    Kardiol Pol; 1982; 25(10-11):967-81. PubMed ID: 6985151
    [No Abstract]   [Full Text] [Related]  

  • 2. [Polish experiment with regard to coronary disease prevention. IV. Incidence of ischemic heart disease among male population aged 40-59 from the Warsaw industrial plants participating in the experiment].
    Rywik S; Kuźmińska A; Charzewska J; Chabros E; Wagrowska H; Przestalska-Malkin H
    Kardiol Pol; 1980; 23(1):73-81. PubMed ID: 7366075
    [No Abstract]   [Full Text] [Related]  

  • 3. [Polish experiment in the prevention of ischemic heart disease. V. Prevalence of coronary disease risk in a male population in Warsaw industrial plants].
    Charzewska J; Rywik S; Chabros E; Wagrowska H; Chotkowska E
    Kardiol Pol; 1980; 23(3):185-93. PubMed ID: 7373969
    [No Abstract]   [Full Text] [Related]  

  • 4. [Polish experiment with regard to coronary disease prevention. III. Arterial hypertension and the effectiveness of its treatment among the male population aged 40-59 years from the Warsaw industrial plants participating in the experiment: Characteristics of the group of persons with hypertension].
    Rywik S; Przestalska-Malkin H; Charzewska J; Chabros E; Wagrowska H
    Kardiol Pol; 1980; 23(1):61-71. PubMed ID: 7366074
    [No Abstract]   [Full Text] [Related]  

  • 5. [The frequency of cardiovascular symptoms in the male population aged 40-59 from the first pair of the Warsaw factories covered by the Polish trial on multifactorial prevention of I.H.D.(author's transl)].
    Rywik S; Charzewska J; Napierala M; Szostak WB; Wagrowska H; Bieganowska K; Michalski E
    Przegl Lek; 1977; 34(8):621-5. PubMed ID: 928808
    [No Abstract]   [Full Text] [Related]  

  • 6. [The general discription of the population of the first pair of the Warsaw factories covered by the Polish trial on multifactorial prevention of I.H.D. (author's transl)].
    Rywik S; Charzewska J; Napierala M; Bieganowska K; Wagrowska H; Szostak WB; Michalski E
    Przegl Lek; 1977; 34(8):615-20. PubMed ID: 928807
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulatory system diseases of select adult population from the rural area.
    Wójcik A; Niedzielski A; Wezgraj W; Lupa K; Borzecki A
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):335-8. PubMed ID: 16146008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polish experiment with regard to coronary disease prevention. II. Arterial hypertension and the effectiveness of its treatment among the male population of the Warsaw industrial plants participating in the experiment: arterial blood pressure].
    Rywik S; Przestalska-Malkin H; Charzewska J; Chabros E; Wagrowska H
    Kardiol Pol; 1980; 23(1):51-9. PubMed ID: 7366073
    [No Abstract]   [Full Text] [Related]  

  • 9. [The distribution of serum cholesterol level in the male population aged 40-59 covered by the Polish trial on multifactorial prevention of IHD (first pair of the Warsaw factories) (author's transl)].
    Chotkowska E; Rywik S; Szostak WB; Napierala M
    Przegl Lek; 1977; 34(8):627-30. PubMed ID: 928809
    [No Abstract]   [Full Text] [Related]  

  • 10. [The "Polish Experiment" with regard to the prevention of coronary disease. III. Effect of the program on morbidity and mortality].
    Rywik S; Sznajd J; Wagrowska H; Koblik T; Konopka M; Kupść W; Magdoń M; Szcześniewska D
    Przegl Lek; 1986; 43(9):596-601. PubMed ID: 3809568
    [No Abstract]   [Full Text] [Related]  

  • 11. [Natural course of ischemic heart disease: comparison of 2 regions of Warsaw].
    Kuch J; Moszczeńska B; Sczaniecka O; Pietkiewicz W; Mamcarz A
    Pol Tyg Lek; 1987 Nov; 42(46):1447-50. PubMed ID: 3444773
    [No Abstract]   [Full Text] [Related]  

  • 12. [The risk factors level and its inter-regional variations in the population covered by the Polish trial on multifactorial prevention of I.H.D. (author's transl)].
    Charzewska J; Rywik S; Szostak WB; Chotkowska E; Chabros E; Sznajd J; Magdoń M; Koblik T; Olszanecki S; Pajak A
    Przegl Lek; 1979; 36(10):715-22. PubMed ID: 515455
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for major cardiovascular risk factors among Members of Polish Parliament as a continuation of health marketing for effective cardiovascular prevention in Poland. Warsaw, May 2006.
    Rutkowski M; Zdrojewski T; Bandosz P; Wierucki L; Piwoński J; Piwońska A; Narkiewicz K; Opolski G; Drygas W; Korewicki J; Wyrzykowski B
    Kardiol Pol; 2007 May; 65(5):486-92; discussion 493-4. PubMed ID: 17577845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mortality trends in cardiovascular diseases in Poland].
    Rywik S; Kupść W
    Kardiol Pol; 1982; 25(10-11):949-57. PubMed ID: 7183818
    [No Abstract]   [Full Text] [Related]  

  • 15. [The dynamic of mortality rates due to cardiovascular diseases with special regards to ischaemic heart disease and hypertension within years 1971--1977. Part I: Mortality pattern of Polish population according to place of residence, sex and age (author's transl)].
    Wagrowska H; Rywik S
    Przegl Lek; 1979; 36(10):699-706. PubMed ID: 515453
    [No Abstract]   [Full Text] [Related]  

  • 16. [The dynamic of mortality rates due to cardiovascular diseases with special regards to ischaemic heart disease and hypertension within years 1971--1977. Part II: Mortality pattern of the population of central and south Poland on the basis of the mortality of Warsaw and Rzeszów populations (author's transl)].
    Rywik S; Wagrowska H; Sznajd J; Magdoń M
    Przegl Lek; 1979; 36(10):707-14. PubMed ID: 515454
    [No Abstract]   [Full Text] [Related]  

  • 17. Is the decrease of cardiovascular mortality in Poland associated with the reduction of global cardiovascular risk related to changes in life style?
    Rywik SL; Piotrowski W; Rywik TM; Broda G; Szcześniewska D
    Kardiol Pol; 2003 May; 58(5):344-55; discussion: 355. PubMed ID: 14523482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The "Polish Experiment" with regard to the prevention of coronary disease. II. Effect of the program on the level of risk factors among high-risk persons].
    Sznajd J; Rywik S; Kulesza W; Olszanecki S; Kocemba J; Przestalska-Malkin H; Swiergul E; Kawecka-Jaszczowa K; Polakowska M; Idzior B
    Przegl Lek; 1986; 43(9):588-95. PubMed ID: 3809567
    [No Abstract]   [Full Text] [Related]  

  • 19. [Assessment of health state in the selected population of rural environment in the aspect of environmental exposure to lead].
    Wójcik A; Wezgraj W; Niedzielski A; Lupa K; Sieklucka-Dziuba M
    Wiad Lek; 2002; 55 Suppl 1(Pt 2):977-82. PubMed ID: 17474631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Basic principles of the prevention of cardiovascular diseases in light of knowledge and opinions of the Polish community. II. Knowledge of coronary disease risk factors].
    Wagrowska H; Piwoński J; Rywik S
    Kardiol Pol; 1989; 32 Suppl 2():47-55. PubMed ID: 2634152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.